Amandine Gouverneur

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Venous Thromboembolism

Metastatic Colorectal Cancer

Top Venues

Expert review of clinical immunology

British journal of clinical pharmacology

Targeted oncology

Journal of the American Geriatrics Society

This page only lists publications with an associated author ORCID identifier.

Publications

Philippe Devillier, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Pascal Demoly
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort. Expert review of clinical immunology (2023)
Philippe Devillier, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Pascal Demoly
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort. Expert review of clinical immunology 20 (4) (2023)
Amandine Gouverneur, Clélia Favary, Jérémy Jové, Magali Rouyer, Emmanuelle Bignon, Francesco Salvo, Achille Tchalla, Elena Paillaud, Thomas Aparicio, Pernelle Noize
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer. Targeted oncology (2023)
Philippe Devillier, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Pascal Demoly
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort. Expert review of clinical immunology 20 (4) (2023)
Amandine Gouverneur, Jerome Avouac, Clément Prati, Jean-Luc Cracowski, Thierry Schaeverbeke, Antoine Pariente, Marie-Elise Truchetet
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study. European journal of clinical pharmacology 78 (12) (2022)
Amandine Gouverneur, Amandine Ferreira, Camille Morival, Cécile Pageot, Marie Tournier, Antoine Pariente
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis. British journal of clinical pharmacology 87 (10) (2021)
Claire Langlade, Amandine Gouverneur, Pauline Bosco-Lévy, Aurore Gouraud, Marie-Christine Pérault-Pochat, Johana Béné, Ghada Miremont-Salamé, Antoine Pariente, null null
Adverse events reported for Mirena levonorgestrel-releasing intrauterine device in France and impact of media coverage. British journal of clinical pharmacology 85 (9) (2019)
Amandine Gouverneur, Julien Bezin, Jérémy Jové, Pauline Bosco-Lévy, Annie Fourrier-Réglat, Pernelle Noize
Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real Life. Journal of the American Geriatrics Society 67 (5) (2019)
Amandine Gouverneur, Pauline Claraz, Marine Rousset, Mickaël Arnaud, Annie Fourrier-Réglat, Antoine Pariente, Thomas Aparicio, Ghada Miremont-Salamé, Pernelle Noize
Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database. Targeted oncology 12 (6) (2018)